Skip to content

Clinical trials

Hidradenitis Suppurativa trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hidradenitis Suppurativa Country / region: China Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20202
20212
20231
20242
20259
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting12
Completed5
Active, not recruiting3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking Union Medical College4
Novartis Pharmaceuticals3
Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.2
Sanofi2
Second Affiliated Hospital, Zhejiang University, School of Medicine2
Staidson (Beijing) Biopharmaceuticals Co., Ltd2
Boehringer Ingelheim1
Merck Sharp & Dohme LLC1
Second Xiangya Hospital of Central South University1
Shanghai Huaota Biopharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hidradenitis Suppurativa22
Dermatitis, Atopic2
Arthritis, Rheumatoid1
Dermatitis1
Hidradenitis1
Pain1

Trials

Showing 26 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.